Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dispersome IP ApS
APS
Active
CVR 44931478
Fruebjergvej 3, 2100
København Ø
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2024 · 1 year old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Dispersome IP ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-0M
-1M
-1M
-1M
-2M
2025
-1M
2026
EBITDA
DKK millions
0M
-1M
-1M
-2M
-3M
-2M
2025
-1M
+50%
2026
Income statement
DKK thousands
Item
2025
2026
Gross profit
-1.882
-1.423
Staff expenses
-0
-0
EBITDA
-1.882
-1.423
Depreciation & amort.
-1.005
-24.834
EBIT
-2.887
-26.258
Net financials
-21
-99
Profit before tax
-2.907
-26.356
Tax
-640
-4.799
Net profit
-2.268
-21.558
Balance sheet
DKK thousands
Item
2025
2026
Total assets
25.169
640
Equity
17.053
-4.505
Long-term debt
0
0
Short-term debt
3.317
5.144
Total debt
3.317
5.144
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-142318000.0%
This company
2025
2026
Equity ratio
-704.2%
This company
38.2%
Market median
-1943% vs market
2025
2026
Return on equity
-2155788100.0%
This company
18.4%
Market median
-11716239774% vs market
2025
2026
Net profit margin (of gross profit)
-2155788100.0%
This company
2025
2026
Asset turnover (of gross profit)
-2.22×
This company
2025
2026
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
2025
2026
Annual reports & filings
Annual report 2026
Filed via CVR / Virk · Period 2025-04-01 – 2026-03-31
View
PDF
Annual report 2025
Filed via CVR / Virk · Period 2024-06-27 – 2025-03-31
View
PDF
More on Dispersome IP ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
